Novo Nordisk

At Novo Nordisk, we are changing diabetes. In our approach to developing
treatments, in our commitment to operate profitably and ethically and in our search for a cure. We know we are not simply treating diabetes, we are helping real people live better. That understanding is behind every decision or action we take, and fuels our passion to change the treatment, perception and future of diabetes for good.

Novo Nordisk is a global healthcare company with 88 years of innovation and leadership in diabetes care. The company also has leading positions within haemophilia care, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk employs more than 31,400 employees in 74 countries, and markets its products in 179 countries.